Discussion
Main findings
ICS has been shown to reduce the need for homologous transfusion during
cesarean section in patients at high risk of
haemorrhage2,12. The autotransfusion rate has been
reported as 21–100% depending on the characteristics of the women who
benefit from ICS13,14. In our study, 33.1% of
patients were reinfused. We found 3 indications that were predictive of
autotransfusion: placenta accreta, uterine fibroids, and postoperative
bleeding. The predictive bleeding threshold for autotransfusion
identified in the ROC analysis was 936 mL.